NeuroSense Therapeutics Ltd.
NRSN · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $666 | $666 | $3,378 | $344 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $847 | $0 | $164 | $406 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $43 | $890 | $35 | $35 |
| Total Curr. Assets | $1,556 | $1,556 | $4,402 | $785 |
| Property Plant & Equip (Net) | $105 | $105 | $150 | $176 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $23 | $23 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $23 | $23 | $0 | $0 |
| Total NC Assets | $128 | $128 | $173 | $199 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,684 | $1,684 | $4,575 | $984 |
| Liabilities | – | – | – | – |
| Payables | $1,093 | $1,093 | $1,160 | $1,392 |
| Short-Term Debt | $0 | $0 | $73 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $0 | $1,110 | $188 | $0 |
| Total Curr. Liab. | $2,203 | $2,203 | $1,992 | $3,783 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $19 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $73 | $19 |
| Total Liabilities | $2,203 | $2,203 | $1,992 | $3,802 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$41,369 | -$41,369 | -$36,660 | -$34,530 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$519 | -$519 | $2,583 | -$2,818 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,684 | $1,684 | $4,575 | $984 |
| Net Debt | -$666 | -$666 | -$3,305 | -$344 |